A genetically-engineered herpes virus is the new hope to beat cancer after scientists found tumours in terminally ill patients were eradicated or shrunk using the groundbreaking new therapy. An early trial at the Institute for Cancer Research (ICR) in revealed that a modified version of the herpes simplex virus showed signs of effectiveness in a quarter of patients with end-of-life cancer. The infection - which also causes mouth and sexually transmitted sores - works on cancer by producing molecules to spark an immune system response and infecting and destroying the cancer.
Load More
Load More